Placeholder text

Development, evaluation and targeting of solid lipid nano-particles

Development, evaluation and targeting of solid lipid nano-particles

0 - Default Title
Description
There is a lot of works done for targeting drug as nanoparticles for the treatment of cancer. But with this work I am anticipating a future scope of nanomedicines for cancer therapy followed by targeting them to lymphatic system. Imatinib mesylate is a drug I selected for this study and the result was shown that this type of therapy is very much effective for lymphoma. SLN can easily pass through the lymphatic system during systemic circulation, and this passive targeting enables the drug to be targeted to the lymphatic system.
Product details
Binding:
Paperback
Number of Pages:
128
Release Date:
2025-11-03
Publication Date:
2025-11-03
Publisher:
LAP LAMBERT Academic Publishing
Languages:
Original: English
ISBN10:
6209179959
ISBN13:
9786209179952
Weight:
209 g
Height:
150 cm
Width:
220 cm
Thickness:
8 cm
Currently sold out